Global Endometriosis Treatment Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Endometriosis affects a large number of women who are in their reproductive age. It is estimated to have a prevalence rate of 1 in 10 among women in the reproductive age group. The number is rising with the growing population count in that age range. Though there isn’t a complete cure for this condition, effective endometriosis treatment is provided through medication which suppresses the extreme pain suffered during endometriosis. There are many assumptions to be taken in order to estimate the correct prevalence of endometriosis patients. The absolute prevalent population is always limited as most cases in developing regions are not reported. Also, the awareness and understanding of different scales of pain is very limited in most regions. Hence, cases of endometriosis often get ignored. The situation persists in not only developing or poor socio-economic countries, but developed countries like the UK, where it is assumed that around 2 million women have undiagnosed endometriosis.

Scope of the Report:
The worldwide market for Endometriosis Treatment Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Endometriosis Treatment Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
AbbVie Inc
Bayer AG
AstraZeneca
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Ipsen Pharma
Myovant Sciences Ltd
Endoceutics, Inc
Debiopharm Group
Mayne Pharma Group

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral Type
Others

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Endometriosis Treatment Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Endometriosis Treatment Drugs, with price, sales, revenue and global market share of Endometriosis Treatment Drugs in 2017 and 2018.
Chapter 3, the Endometriosis Treatment Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Endometriosis Treatment Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Endometriosis Treatment Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Endometriosis Treatment Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
1.1 Endometriosis Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Oral Type
1.2.2 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 E-Commerce
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie Inc
2.1.1 Business Overview
2.1.2 Endometriosis Treatment Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Inc Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer AG
2.2.1 Business Overview
2.2.2 Endometriosis Treatment Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer AG Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Endometriosis Treatment Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer Inc
2.4.1 Business Overview
2.4.2 Endometriosis Treatment Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Inc Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teva Pharmaceutical Industries Ltd
2.5.1 Business Overview
2.5.2 Endometriosis Treatment Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Ipsen Pharma
2.6.1 Business Overview
2.6.2 Endometriosis Treatment Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ipsen Pharma Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Myovant Sciences Ltd
2.7.1 Business Overview
2.7.2 Endometriosis Treatment Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Myovant Sciences Ltd Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Endoceutics, Inc
2.8.1 Business Overview
2.8.2 Endometriosis Treatment Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Endoceutics, Inc Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Debiopharm Group
2.9.1 Business Overview
2.9.2 Endometriosis Treatment Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Debiopharm Group Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Mayne Pharma Group
2.10.1 Business Overview
2.10.2 Endometriosis Treatment Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mayne Pharma Group Endometriosis Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Endometriosis Treatment Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Endometriosis Treatment Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Endometriosis Treatment Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Endometriosis Treatment Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Endometriosis Treatment Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Endometriosis Treatment Drugs Market Analysis by Regions
4.1 Global Endometriosis Treatment Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Endometriosis Treatment Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Endometriosis Treatment Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
4.5 South America Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
5 North America Endometriosis Treatment Drugs by Country
5.1 North America Endometriosis Treatment Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Endometriosis Treatment Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Endometriosis Treatment Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
6 Europe Endometriosis Treatment Drugs by Country
6.1 Europe Endometriosis Treatment Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Endometriosis Treatment Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Endometriosis Treatment Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
6.3 UK Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
6.4 France Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Endometriosis Treatment Drugs by Country
7.1 Asia-Pacific Endometriosis Treatment Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Endometriosis Treatment Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Endometriosis Treatment Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
7.5 India Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
8 South America Endometriosis Treatment Drugs by Country
8.1 South America Endometriosis Treatment Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Endometriosis Treatment Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Endometriosis Treatment Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Endometriosis Treatment Drugs by Countries
9.1 Middle East and Africa Endometriosis Treatment Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Endometriosis Treatment Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Endometriosis Treatment Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Endometriosis Treatment Drugs Sales and Growth Rate (2014-2019)
10 Global Endometriosis Treatment Drugs Market Segment by Type
10.1 Global Endometriosis Treatment Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Endometriosis Treatment Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Endometriosis Treatment Drugs Revenue and Market Share by Type (2014-2019)
10.2 Oral Type Sales Growth and Price
10.2.1 Global Oral Type Sales Growth (2014-2019)
10.2.2 Global Oral Type Price (2014-2019)
10.3 Others Sales Growth and Price
10.3.1 Global Others Sales Growth (2014-2019)
10.3.2 Global Others Price (2014-2019)
11 Global Endometriosis Treatment Drugs Market Segment by Application
11.1 Global Endometriosis Treatment Drugs Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Retail Pharmacies Sales Growth (2014-2019)
11.4 E-Commerce Sales Growth (2014-2019)
11.5 Others Sales Growth (2014-2019)
12 Endometriosis Treatment Drugs Market Forecast (2019-2024)
12.1 Global Endometriosis Treatment Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Endometriosis Treatment Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Endometriosis Treatment Drugs Market Forecast (2019-2024)
12.2.2 Europe Endometriosis Treatment Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Endometriosis Treatment Drugs Market Forecast (2019-2024)
12.2.4 South America Endometriosis Treatment Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Endometriosis Treatment Drugs Market Forecast (2019-2024)
12.3 Endometriosis Treatment Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Endometriosis Treatment Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Endometriosis Treatment Drugs Market Share Forecast by Type (2019-2024)
12.4 Endometriosis Treatment Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Endometriosis Treatment Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Endometriosis Treatment Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source